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Summary
Shrinkage estimation of large-scale sparse covariance matrix is an im-
portant technique in the exploratory analysis of high-dimensional data sets.
We propose a two-step procedure to estimate large-scale covariance matrix
for one set of variables X with known group information, followed by es-
timation of covariance matrix between X and another set of variables Y,
denoted by ΣXX and ΣXY respectively. The covariance matrix ΣXY is es-
timated as the product of two components, namely ΣXXB. Similar to the
idea of Fan et al. (2013)’s Principal Orthogonal complEment Thresholding
(POET) estimator, ΣXX is decomposed into a systematic factor component
and an idiosyncratic component ΣXX = Σf+Συ in the first step, where the
former explains the variability associated with known groups and the latter
the residual variability in X. B is estimated using the group lasso based on
x
the selected groups from the first step. We present the asymptotic prop-
erties of the two-step estimator with appropriate conditions. We illustrate
the methodology using simulations and the mRNA expression data from
The Cancer Genome Atlas (TCGA), focusing on the covariance structure





A plethora of statistical methods have been developed for the analysis of
high-dimensional molecular data over the past decade, creating a large body
of statistical methods for sample classification and prediction, multiple
testing correction (Benjamini and Hochberg, 1995; Storey, 2002), and inte-
grative data analysis of multi-platform molecular data sets (Leˆ Cao et al.,
2009; Sass et al., 2013; Shen et al., 2009, 2013; Troyanskaya et al., 2003).
An important area of application that has received attention of late is the
inference of gene-to-gene association or gene regulatory network inference,
aiming to identify gene modules, which reflect that those molecules within a
module are functionally related in the context of the given molecular study
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(Baraba´si et al., 2011; Mitra et al., 2013; Oldham et al., 2008; Segal et al.,
2003a,b, 2004; Stuart et al., 2003; Vidal et al., 2011; Zhang and Horvath,
2005). Such methods are applicable to both controlled experiments over
distinct conditions in model systems and population studies of humans, and
the analysis often reveals context-specific gene-gene interactions associated
with relevant biological functions.
In the recent statistics literature, this problem has been formulated as
large-scale covariance matrix estimation under sparsity assumptions. The
premise that the correlation structure is sparse bodes well with the biolog-
ical reality, in which a small number of functionally related molecules leads
to sparse specification of non-zero elements in the covariance matrix. Devel-
opment of this methodology initially started with element-wise shrinkage
estimators in scenarios where the general correlation structure is known
(e.g. banding estimator in time series data (Bickel and Levina, 2008b))
and where such structure is unknown (Rothman et al., 2009). Similar to
the development of the Least Absolute Shrinkage and Selection Operator
(lasso) (Tibshirani, 1996) regression techniques, a more adaptive estimator
has also been developed (Cai and Liu, 2011). The theoretical properties
such as the convergence rates and selection/consistency have been well
established (Bunea et al., 2007; Knight and Fu, 2000). A more relevant
development to our work here was that of the Principal Orthogonal com-
plEment Thresholding (POET) estimator, a shrinkage estimator of large
covariance matrix by thresholding principal orthogonal complements, the
idea of which we extend in our proposal later (Fan et al., 2013).
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A common assumption in the existing shrinkage estimation methods
is that each covariance term, between two molecular features such as two
genes in a microarray experiment, is perceived as an independent unit on
its own and thus element-wise shrinkage can be applied to each element
independently to yield sparsity in the entire covariance matrix. In biolog-
ical applications, however, a large collection of experimentally validated
relational data are now available and their coverage of the entire “interac-
tome” has substantially increased, and therefore the knowledge of protein
complexes, pathways, and even the functional annotations such as gene on-
tology, can be further utilized to better identify groups of more than several
functionally related covariances, i.e. beyond a pair of molecules. Accord-
ingly, it will be a desirable development if the existing group information
can be incorporated into the sparse covariance matrix estimation, which is
expected to guide more precise identification of co-regulated gene modules
that are coherent with current biological literature.
1.2 Cross-covariance Matrix Estimation in
Biological Applications
This thesis is primarily concerned with two-stage estimation of the
large-scale cross-covariance matrix between two sets of variables (molecules)
X and Y, where a part of the estimator consists of full covariance matrix
estimation for X using group information. This formulation is motivated by
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real biological questions where one set of variables X represents upstream
regulatory molecules such as those in the upstream signaling cascade and
the other set of variables Y is their downstream regulatory targets or sub-
strates. In this situation, the covariance between the two variables are
estimated in a way that incorporates the group structure between the el-
ements of X or that of Y. We reformulate the problem into the familiar
regression setup, in which each element of Y is expressed as a linear func-
tion of X and a noise component, and the covariates X are expected to be
highly correlated in the high-dimensional regression.
First stage estimation
When the covariates are correlated, a popular solution in the regression
is to use a class of factor models, where each factor is a weighted linear
combination of elements of X. One example is the principal component re-
gression (Jolliffe, 1982), where the principal components, computed as the
eigenvectors of the sample covariance matrix, are used as regressors. De-
spite great utility as a dimension reduction technique, it is well known that
the practical problem with the principal component regression approach
is that the factors (e.g. principal components) hardly lend themselves to
straightforward interpretation and it involves arbitrary thresholding to as-
sign associated genes to each factor. An ideal scenario is where a major
factor is defined by a fixed set of variables (genes) with known biological
annotation such as pathway or gene functions, yet it is difficult to have
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clear-cut assignment of one gene to one group of variables in complex sys-
tems because individual genes are often involved in more than one functions
in a multifactorial manner.
From a biologist’s point of view, the most informative analysis is to
directly decompose the correlation of X, denoted by ΣXX, into two com-
ponents, one representing the correlation that is attributable to known
biological relationship (or grouping information hereafter), and the other
representing the correlation associated with unknown sources. Borrowing
the definitions from the POET estimator, we shall call them the system-
atic component Σf and the idiosyncratic component Συ, respectively. The
underlying assumption is that the factors associated with known group in-
formation are sparse, and that with the shrinkage estimate of the residual
covariance matrix, the covariance matrix of X can be estimated consis-
tently and the semi-positive definiteness is guaranteed for the final estimate
of ΣXX under mild conditions.
Second stage estimation
Our ultimate goal is to estimate the cross-covariance matrix ΣXY and
to deduce how much of the total variability is attributable to the known
biological relationship and how much is not. The covariance between X
and Y is expressed as ΣXXB, where B is the regression coefficient matrix
and each column bj of B is the regression coefficient of yj ∼ X. Here, the
selected factors from the first stage estimation is utilized as the “groups”
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in the second stage estimation of the regression coefficient matrix B. Since
the group information explicitly specifies which variables in X are associ-
ated with each factor, the selected groups can be used in forming grouped
lasso regression between X and Y, to yield a sparse linear model that
incorporates the known biological grouping information in the covariates
contributing to ΣXX. The outcome of the analysis is the decomposition
of the cross-covariance due to the systematic component ΣfB and the id-
iosyncratic component ΣυB.
1.3 Literature Review
Before we introduce the method, we first review the relevant statistics
literature in the field of shrinkage estimation and large-scale covariance
matrix estimation.
1.3.1 Review of shrinkage methods
Consider a linear regression model, Y = Xβ + , where X is a n × p
matrix, Y and  are vectors of length n, and without loss of generality, let us
assume Y and each column of X has zero mean. An ordinary least squares
(OLS) estimate is obtained by minimizing the residual squared error:




In high dimensional data, however, the coefficients are non-zero for all OLS
estimates even when only a small subset of variables are indeed significant
predictors. While the OLS estimates are unbiased, the prediction error will
not be properly minimized if all variables are retained since the variance of
the estimated response will be large with increasing model complexity.
The lasso (Tibshirani, 1996) is a popular method that addresses the
drawback of OLS, which embodies a penalized least squares with L1-penalty.
Instead of minimizing the residual squared error, a penalty is imposed on
the regression coefficients β along with the loss function, i.e.
βˆlasso = arg min
β
‖Y −Xβ‖22 + λ ‖β‖1
The entire solution path (varying λ) of the lasso can be either approximated
by the LARS algorithm (Tibshirani et al., 2004), or explicitly obtained
through efficient algorithms such as coordinate descent (Ho¨fling and Tibshirani,
2007). It has a continuous piecewise linear solution path and coefficients are
set to zero as the shrinkage increases. In particular, Knight and Fu (2000)
shows that when the true regression coefficient is zero, its lasso estimate has
a positive probability at zero, which allows for automatic variable selection
and efficient computation of the optimal tuning parameter. However, the
lasso has some limitations itself. As pointed out in Zou and Hastie (2005),
if a group of highly correlated predictor variables exists, it tends to select
only one variable among the group. In addition, the lasso performs variable
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selection for individual predictors, and thus the method is not directly ap-
plicable if there exists a natural grouping in the predictors and such group
structures are desired to be reflected in the selection procedure.
The group lasso (Yuan and Lin, 2006), defined as














was proposed to do group variable selection to address situations where
there exists a natural grouping in the regression coefficients. Unlike the
lasso, the solution path of group lasso is not piecewise linear in general and
therefore finding the optimal tuning parameter requires intensive compu-
tation over a suitably fine grid of values. For a fixed tuning parameter,
Yuan and Lin proposed a block coordinate-wise minimization method to
compute the solutions. Each coordinate descent step is fast, with an ex-
plicit formula yielding the minimum for a coordinate. Theoretical prop-
erties of the group lasso for linear models has been first established in
Nardi and Rinaldo (2008). In addition to the theoretical conditions for
some optimality properties, Nardi and Rinaldo showed that those condi-
tions are valid for the double-asymptotic scenario in which the dimension
of the parameter space grows with the sample size.
We also remark that computational methods for shrinkage methods is a
well-researched topic. Specialized methods such as LARS are efficient, but
cannot be applied when the regression type is changed, for example from
linear model to generalized linear model, or when the penalty function is
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replaced with another. Pathwise coordinate optimization are shown to be
versatile in Ho¨fling and Tibshirani (2007) for various shrinkage methods
and the authors showed by comparing run times of programs for the al-
gorithms, that coordinate-wise descent is very competitive with the LARS
algorithm. The authors later extended their work for general linear models
in Friedman et al. (2010). Our work utilizes the group lasso penalty to
identify significant factors in the predictor variables. We have also used
a block coordinate decent algorithm by Yuan and Lin (2006) to find the
solution path.
1.3.2 Review of Sparse Covariance Matrix Estima-
tion
Element-wise shrinkage of estimates was first proposed in Bickel and Levina
(2008b). In their work, they developed shrinkage estimator of covariance
matrix or precision matrix (inverse) for a specific class of covariance ma-
trices, where the variables are ordered in a way that the true covariance
matrix is a banded matrix (e.g. time series data). The shrinkage estimation
was applied by banding, i.e. penalizing the covariance terms between vari-
ables that are not close enough, or banding the Cholesky decompositions of
the covariance matrix as such. The authors have proven the optimality of
the estimators under the operator norm for a family of covariance matrices
thereafter.
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However, banding of estimates is not applicable to problems where
an ordering is not available. In their follow-up paper, Bickel and Levina
(2008a) also investigated element-wise hard-thresholding estimator in a
more generalized setting. In a similar way, Rothman et al. (2009) pro-
posed a more generalized class of thresholding operators with element-
wise shrinkage based on various penalty functions, and showed that their
method is consistent and “sparsistent”, implying that the locations of zero
and nonzero elements are estimated correctly with probability tending to
1. In their simulations, they demonstrated that, when the matrix is sparse,
thresholding based on the smoothly clipped absolute deviation (SCAD)
(Antoniadis and Fan, 2001) penalty function, i.e.
pλ (z) =

sgn (z) (|z| − λ) when |z| ≤ 2λ
(a−1)z−aλsgn(z)
a−2 when 2λ < |z| ≤ aλ
z otherwise
performed the best in terms of sparsity. More recently, Cai and Liu (2011)
proposed an adaptive version of element-wise shrinkage estimator that takes
into account the variability of the estimate of each entry in the matrix, i.e.
for heteroscedastic problems. In their method, the shrinkage parameter
is tailored for each entry, rendering their thresholding rule non-universal
(or uniform), and the choice of thresholds is completely data-dependent.
Cai and Liu showed that their estimator achieves superior optimal rate of
convergence or a wide class of sparse covariance matrices.
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Lastly, Fan et al. (2013) proposed the principal orthogonal complement
thresholding (POET) method. The method depends only on the sample
covariance matrix, which is expressed as the sum of systematic component













where optimal Kˆ can be estimated from the data. A element-wise thresh-
olding procedure is applied to attain regularized residual covariance matrix.
Our proposal for sparse cross-covariance estimator borrows the idea of the
POET estimator. While principal components are the entities being se-
lected in POET, we form explicit groups of variables as factors reflecting
the biological relationship and select significant factors as part of the de-
composition of the covariance matrix into the systematic component. Using
the knowledge of systematic component, we establish the relationship be-
tween the sparse set of variables (with specific biological functions) with
the outcome variables via group lasso.
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CHAPTER 2
The Cancer Genome Atlas
Breast Cancer Data
2.1 Introduction
Integrative analysis of multiple high-throughput data is becoming in-
creasingly popular in clinical studies, best exemplified by The Cancer Genome
Atlas (TCGA) project (http://cancergenome.nih.gov/). Unlike conven-
tional genomic studies relying on a single platform, TCGA is the first
project providing multi-omics data sets across all popular platforms includ-
ing massive parallel sequencing, mRNA expression arrays, DNA methyla-
tion, microRNA expression, reverse-phase protein assay (RPPA), and more
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recently mass spectrometry-based proteomics. In the invasive breast can-
cer cohort (Koboldt et al., 2012), for example, these technologies have been
performed on the tumor samples from >800 patients in four major basic
therapeutic groups previously defined by PAM50 mRNA expression clus-
ters (Parker et al., 2009), including the luminal A and B groups consisting
of estrogen receptor and progesterone positive group, the HER2 enriched
group, and the basal-like group mostly represented by tumors with low
expression of all three hormones. This project provides by far the most
comprehensive molecular landscape of this therapeutically diverse disease.
Integration of multiple data sources can be done in many different
ways, depending on the purpose of study. For example, expression quan-
titative trait loci (eQTL) studies aim to identify local and distant ge-
netic regulation of mRNA transcript expression (Chun and Keles, 2009;
Kendziorski and Wang, 2006; Rockman and Kruglyak, 2006). The most
popular statistical approach in this area is multivariate regression with
shrinkage estimation (L1 penalty) between RNA data (response) and ge-
netic loci (as predictors). On a similar line of methods, Peng et al. (2010)
has developed RemMap, a method for evaluating the dependence of RNA
transcript abundance on the DNA copy numbers in cancer genomics data
via multivariate regression that can incorporate prior kwowledge to avoid
penalization of known regulatory relationships. More recently, the so-called
proteogenomics approaches surfaced in the proteomics literature, investi-
gating the correlation between mRNA transcript and their corresponding
protein abundance, the final gene product of the RNA (Zhang et al., 2014).
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However, their analysis focuses on RNA-protein correlation within the same
gene and the association between splice variants and protein isoforms rather
than correlation of quantitative data between different genes (Zhang et al.,
2014).
While estimation of invertible, sparse covariance matrix is generally
of primary interest in high-dimensional data analysis, cross-covariance (or
correlation) matrix, which is a subset of the entire variance-covariance ma-
trix, is also a biologically important quantity of interest in integrative data
analysis setting since it represents the association between distinct molec-
ular types. Representative examples are when one molecular type is a
precursor to the other in the central dogma of molecular biology (DNA to
RNA, RNA to protein), or when one data type captures regulatory infor-
mation to the other. For example, DNA methylation data coupled with
mRNA transcriptomics data allows us decipher the transcriptional repres-
sion of the latter by the former. Likewise, expression data for non-coding
RNAs known as microRNAs coupled with proteomics data will also reveal
the degree of post-transcriptional regulation. Hence robust estimation of
the cross-covariance matrices is of great importance in understanding the
dependence between precursors and gene products or functionally active
regulatory information in multi-omics data sets such as TCGA.
Estimators of large-scale sparse covariance matrices have typically been
developed under sparsity assumption, and it is reasonable to expect this
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condition to hold true in biological applications with high-throughput ex-
perimental data. Hence the major computational approach is to regu-
larize individual elements of the covariance matrix by thresholding, em-
bodying shrinkage estimation techniques. These methods have the obvious
advantage of easy implementation and is known to perform well in numer-
ical simulations, further strengthened by theoretical properties with suf-
ficiently sharp convergence rates (Bickel and Levina, 2008b; Cai and Liu,
2011; Rothman et al., 2009). Despite the technical developments over the
years, it is nevertheless rare to find a case where a shrinkage estimator of
large-scale covariance matrix yielded novel biological insights in a real bio-
logical or clinical problem. Moreover, with a few exceptions, the examples
in the published articles are typically demonstrated with no more than a
few hundreds of genes, which diminishes the applicability to data sets with
typically thousands of features or variables.
One possible way to broaden the applicability of these estimators in
biological problems is to utilize gene group information in the estimation
procedure. We use the terms ‘gene group’ and ‘pathway’ interchangeably
hereafter. To the best of our knowledge, the only development using group
information for shrinkage estimation of large-scale covariance matrix is the
work of Levina et al. (2008) in the case where there is natural ordering
in the variables. In population genomic studies, such intervention based
on curated gene groups will benefit the estimation since we can impose
sparsity at the level of biological functions, not individual genes. This is
an attractive solution given that the pairwise sample covariance terms not
15
only represent the direct outcome of differential regulation of important
biological pathways, but they also reflect the indirect consequences not as-
sociated with the regulation of pathways. In such situations, guiding the
shrinkage estimation procedure by known gene grouping information can
enable decomposition of the non-zero covariances due to the pathway-level
regulation (systematic component) and the residual covariances (idiosyn-
cratic component). This is the main motivation for our proposal to develop
a novel procedure for cross-covariance matrix estimation.
2.2 Approach
As mentioned earlier, we analyze the DNA methylation and mRNA ex-
pression data from the invasive breast cancer cohort (BRCA) of TCGA. The
TCGA-BRCA published in 2012 (Koboldt et al., 2012) has reported signif-
icant heterogeneity within and across different subtypes of breast cancer at
multiple molecular levels. The single nucleotide polymorphism (SNP) ar-
rays and whole exome sequencing revealed three highly common mutation-
harboring genes such as TP53, PIK3CA, and GATA3, and highlighted
numerous subtype-specific mutations. In addition, the availability of mul-
tiple -omics platform data and reverse-phase protein assay allowed them to
discover additional subtypes within the previously defined luminal subtype




















































































Figure 2.1 (A) mRNA transcript expression and (B) DNA methylation
data for kinases and their substrate genes involved in T cell co-stimulation,
which involves T cell receptors and mTORC2 complex. Rows and columns
are ordered according to the hierarchical clustering of the mRNA data.
In our analysis, we aim to identify epigenetic regulation of mRNA tran-
script expression via DNA methylation at the pathway-level. Figure 2.1
shows the heat map of both molecular data for 30 genes in 766 primary
tumor samples that meet two criteria: (i) each gene has to be either a ki-
nase and kinase substrate (227 kinases and 764 non-kinase substrates) and
(ii) it is involved in a particular biological process, T cell co-stimulation in
this case. The diagram clearly shows that these genes are correlated at the
mRNA transcript with a few exceptions (top), and the expression pattern
is negatively correlated with the DNA methylation data (bottom). In other
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words, although there are other mechanisms of transcriptional regulation,
DNA methylation seems to play an influential role in determining mRNA
concentration levels for genes involved in T cell activation within the kinase
signalling network.
To identify pathway-specific regulatory patterns of DNA methylation
and their association with mRNA expression, we build our cross-covariance
matrix between the two molecular data in two stages as follows. In the first
stage, we detect pathway-specific factors in DNA methylation by estimat-
ing the variance-covariance matrix of the data. Following the approach of
POET estimator (Fan et al., 2013), we decompose the matrix as the sum
of a systematic component explained by pathway-specific factors and an id-
iosyncratic component representing the residuals. Both components are es-
timated with group penalty and element-wise penalty respectively, to yield
sparse estimates. In the second stage, the gene group information from
the pathways selected with non-zero factors in the first stage is used again
to estimate the multivariate regression model between DNA methylation
and mRNA expression with group lasso (Yuan and Lin, 2006), where we
slightly modify the estimation procedure to allow overlapping groups. The
two components naturally yield decomposition of the cross-covariance ma-
trix into a systematic and an idiosyncratic one, with the former representing
pathway-specific regulation of mRNA expression via DNA methylation.
Note that we forgo a straightforward element-by-element calculation of
covariance between DNA methylation of one gene and mRNA of another
18
gene (including self-to-self). This more cumbersome estimation routine is
motivated by the ability of the two-stage estimation procedure to proac-
tively utilize the existing gene group information to distinguish concerted
regulation of gene expression at the pathway level. This decomposition
will help us to determine how much of the cross covariance structure is a
representation of coordinated biological functions and also to evaluate how
complete or incomplete the existing knowledge of biological functions is.
Moreover, the applicability of the same methodology is quite wide as far




Suppose the two sets of variables Xi and Yi, vectors of dimensions
(p× 1) and (q × 1) respectively, are observed for subject i = 1, . . . , n. We
arrange them into their respective matrix form X(n×p) and Y(n×q) where

















where the superscript T denotes transpose of a vector of a matrix. We
aim to estimate the cross-covariance matrix ΣXY as the product of two
components, i.e. ΣXXB, and we thus construct the estimator for ΣˆXX and
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vectors µX, µY and covariance matrices ΣXX, ΣXY, and ΣYY are defined
as (p × p), (p × q), and (q × q) submatrices of (p + q) × (p + q) variance-
covariance matrix Σ. Further, we let (p×G) matrix A = {a`g} indicating
the group assignment of p variables into G groups, with a`g = 1 if the
variable ` is a member of group g and a`g = 0 otherwise. Since the mean
parameters can be estimated from the data, we assume zero mean hereafter
without loss of generality.
Given that the variable grouping A is known, we assume that the el-
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≡ Afi + υi. (3.4)
Rearranging the data for all subjects i = 1, . . . , n, we can represent the
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= Anf + Υ, (3.6)
where 1np is np− dimensional vector of ones, An is the block diagonal ma-
trix consisting of n numbers of (p×G) matrix A, and Υ is np−dimensional
distribution with mean 0 and covariance matrix as the block diagonal ma-






= ΣXX = AΣfA
T + Συ. (3.7)
3.1 Estimation in Stage 1

















= λf f.k. (3.9)




∥∥~X−Anf∥∥22 + 12 1log(np){∑Gk=1 f2.k + 2(np) · log(np) · λf∑Gk=1 f.k)}.
(3.10)
Since typically fewer than G factors will be retained as a result of penalized
regression, we use G0 to denote the number of selected random factors.




to get the predictive value f̂ of f to avoid extreme shrinkage and estimate












where f̂ is the sample mean of f̂1, f̂2, . . . , f̂n. If the factors are orthogonal,
then Σf = diag
(
τ 21 , τ
2
2 , · · · , τ 2G0
)




as an estimator of Σf .




To estimate the idiosyncratic component of Συ, we apply the general-
ized thresholding to the sample covariance matrix of ~X−Anf̂ . Various esti-
mators are proposed in Antoniadis and Fan (2001), Rothman et al. (2009),
and Cai and Liu (2011). In particular, we use the adaptive thresholding
procedure of Cai and Liu (2011) using the sample covariance estimate using












where ξi = Xi −Af̂i and sλυ(M) denotes the adaptive shrinkage operator
of matrix M.
3.2 Estimation of B by grouped lasso
The second stage of the estimation is fitting the regression model
Yi = B
TXi + ui (3.14)
for i = 1, · · · , n, where Yi and ui are q-dimensional vectors, and B is p× q
matrix of coefficients. Note that, by rearranging {Yi}ni=1 and {ui}ni=1 into
matrices of q columns and {Xi}ni=1 into a matrix of p columns, both row-
wise, we recover the original matrix notations Y, U, and X respectively
and
Y = XB + U. (3.15)
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Here Y is (n × q) matrix where each row is Yi, U is a matrix whose
i−th column is ui following the multivariate distribution with mean 0 and
covariance matrix ΣYY −ΣYXΣXXΣXY.
Although it is known that B = ΣXX
−1ΣXY, here we consider the
grouping information of X in the estimation of B. To achieve this, we
propose to formulate this as a grouped lasso regression (Peng et al., 2010;















is grouped lasso penalty. The group lasso penalty imposed in
this regression comes from the matrix A used in the first stage estimation
of factors, especially for the selected factors. Denote the index set of all
the features of X belonging to a selected factor g by Gg. Then the penalty















where bij denotes the elements of B. Upon obtaining B̂, the final estimate
of ΣXY becomes
Σ̂XY := Σ̂XXB̂. (3.18)
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3.3 Numerical Algorithm
Stage 1: Selection and Estimation of Factors
Without loss of generality, let us assume that each column of X is
centered. Let ρ = 1
log (np)















with respect to {fi}ni=1. Following Zou and Hastie (2005), we merge the
ridge penalty into the loss function by augmenting An with a diagonal


































































f∗,j = (f1j, f2j, . . . , fnj)
T ,
A∗,j is the jth column of A, Aj is the jth column of An, and apply the path-
wise coordinate optimization for the group lasso (Ho¨fling and Tibshirani,
2007; Yuan and Lin, 2006). Define γj = f∗,j/cj. Then we update each γj
by
γj ←
























for all j = 1, . . . , G. Note that the formula for Sj can be simplified to avoid












To set the value of λf , we use the Akaike Information Criterion (AIC)
(Akaike, 1973) defined by AIC = 2k − 2 ln(L), where k is the number of
non-zero estimates of the parameters and L is the maximized value of the
likelihood. If we denote the number of selected groups for each gene by Gi











When all coefficients are zero, γj will remain as zero after the up-
date as shown in (3.25) if ‖Sj‖2 = cj





Stage 2: Group lasso with overlapping groups






) ≡ L + P. (3.30)
Note here that each row of B is independent of each other in the objective
function, and thus the optimization can be carried out in parallel.
For the group lasso regression in the second stage, we perform pathwise
coordinate gradient descent (Ho¨fling and Tibshirani, 2007). Denote the
matrix created by combining the columns of A selected in Stage 1 as A0.
























Figure 3.1 Grouping for stage 2. The 1’s in matrix A represents a group
membership.
as a group. However, predictor variable with a row pattern of all zeros
are regarded as a singleton. Figure 3.1 illustrates the grouping for stage
2. We then partition Xi by its columns according to the gene groups,
and orthonormalize each matrix Xgi in the resulting set of matrix. The
algorithm in Stage 1 is used to find B. Let Bjg be the elements in group g
in the j-th column of B. Iteratively update the estimate of B with
Bjg ←





















In this section, we show that the proposed cross-covariance estimator
Σ̂XY converges to ΣXY in the Frobenius norm and also show that both B̂
and f̂ have consistency in selecting non-zero elements of B and f .
4.1 Notations
We fist introduce necessary notations to be used in the theorems and
their proofs. For easy comparison with the results in the literature, we
rearrange the data X and Y introduced in Section 3 into variable forms of
vectors or matrices wherever it is deemed to facilitate the statement and
proof (especially for the two estimation stages). To begin with, we rewrite
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the model (3.14) for the second stage estimation using the vectorized no-







































































, and ~u =
(
u1, u2, . . . , unq
)T
. In addition to the
expanded form of the matrix X˜, we recall the factor model for X in (3.5),
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= Anf + Υ, (4.2)
where 1np is a np−dimensional vector of ones, An is the block diagonal
matrix by n numbers of A, and Υ is np−dimensional distribution with
mean 0 and covariance matrix as the block diagonal matrix of Σν .
We next define the set of indexes of groups of variables. First, related
with the regression model (4.1) with true β = β0, we letH0 =
{
g | ∥∥β0g∥∥ 6=
0, g = 1, 2, . . . , G
}
and G0 =
∣∣H0∣∣, which are the index sets of groups with
non-zero coefficients and its cardinality. Elementwise, we let L =
{
j | 1 ≤
j ≤ pq} and L0 = {j ∈ L ∣∣β0j 6= 0}. For the g−th group, g = 1, 2, . . . , G,
we let Ig be the set of indexes of its elements, dg =
∣∣Ig∣∣, Jg,h = Ig⋂Ih
and dg,h =




∥∥βg∥∥, where βg the vector of {βj, j ∈ Ig} and the
tuning parameter was renamed from λB to λβ due to the rearrangement of
regression coefficients into the vector form.
The element-wise index set A introduces X˜A, a submatrix with column
vectors X˜.j for j ∈ A. This defines X˜g for g = 1, 2, . . . , G, and X˜g1,g2 =(




for g1, g2 ∈ {1, 2, . . . , G}. In particular, the set L0
partitions the design matrix X˜ into X˜0 and X˜1, where X˜0 is an (np)×|L0|
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matrix with column vectors X˜.j, j ∈ L c0 .
For the factor model (4.2), we assume that, for j = G0+1, G0+2, . . . , G,





∣∣ j = (i− 1) ·G+ k, i = 1, 2, . . . , n, k = 1, 2, . . . , G0}, (4.3)
which is the set (of indexes) of non-zero elements. Along with the given
index sets I0, let fi.1 =
(







f0 be the (np)× 1 random vector whose j-th element is equal to that of f
if j ∈J0 and 0 otherwise. Thus,
Σf =
 Σf .11 0
0 0
 , (4.4)
where Σf .11 is the G0 ×G0 sub-matrix of Σf .
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4.2 Consistency of Σ̂XY
Next, we show the convergence of Σ̂XY to ΣXY in the Frobenius norm.
To show this, we first find
∥∥Σ̂XY − ΣXY∥∥F = ∥∥ΣˆXXB̂−ΣXXB∥∥F
≤ ∥∥ΣˆXXB̂−ΣXXB̂∥∥F + ∥∥ΣXXB̂−ΣXXB∥∥F
≤ ∥∥ΣˆXX −ΣXX∥∥F∥∥B̂∥∥F + ∥∥ΣXX∥∥F∥∥B̂−B∥∥F
≤ p
{∥∥ΣˆXX −ΣXX∥∥F∥∥B̂∥∥∞ + ∥∥ΣXX∥∥∞∥∥B̂−B∥∥F}
≤ p
{∥∥ΣˆXX −ΣXX∥∥F{∥∥B∥∥∞ + op(1)}+ ∥∥ΣXX∥∥∞∥∥B̂−B∥∥F} ,
where the infinity matrix norm for matrix B = (bij) is defined as
∣∣B∣∣∞ :=
maxij |bij|. Thus, we show the convergence of
∥∥B̂−B∥∥
F
(Theorem 1) and∥∥ΣˆXX−ΣXX∥∥F (Theorem 2) along with the boundedness assumptions on∣∣B∣∣∞ and ∣∣ΣXX∣∣∞.
We first show the convergence of B̂ which is the grouped lasso es-
timator of a multivariate multiple regression in the second stage. The
asymptotic properties of the the grouped lasso estimator are studied by
Nardi and Rinaldo (2008) when the groups are mutually exclusive. Theo-
rem 1 below is a modification of Theorem 4.5 of Nardi and Rinaldo (2008)
for the estimator allowing overlapping variable groups. Its proof mainly
depends on the inequalities from Lemma 1 in the Appendix of Bunea et al.
(2007).
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The assumptions we make for the theorem are as follows. First, we as-
sume u˜is are independent and identically distributed from the normal dis-
tribution with mean 0 and variance σ2u. Second, we assume the restricted
eigenvalue (RE) condition which is known to be necessary for the `2 con-
sistency of the estimator (Bickel et al., 2009). Define a set of sub-vectors







β ∈ Rpq : ∥∥βSc∥∥ ≤ α∥∥βS∥∥, ∀|S| = k}. (4.5)












Along with the RE condition, one additional assumption is needed related






 ≤ κming λg. (4.7)

















∥∥X˜Tg u∥∥2 < √nq λλg} (4.9)
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occurs with probability tending to 1.
Now we state our Theorem 1 on the convergence of B̂ to B.
Theorem 1. Under the four assumptions above,















)} · λ2, (4.10)





converges to 1, as n→∞.
4.3 Proof of Theorem 1
Proof. The proof of the theorem is an extension of Theorem 4.5 of Nardi and Rinaldo
(2008) to the grouped lasso estimator with overlapping groups. We briefly
summarize their proof and explain the changes induced by allowing the























∥∥β̂g − β0g∥∥22, (4.12)
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where the last is bounded from the RE condition to η = β̂ − β (shown
later).
The inequality (4.11) is obtained by modifying Lemma 1 of Bunea et al.
(2007) for the grouped lasso penalty. The modified Lemma 1 (which is the
same with Lemma 6.1 of Nardi and Rinaldo (2008)) states that, on the
event E1, for any β ∈ Rpq with H ′ =
{


















∥∥β̂g − βg∥∥2 (4.13)
The extension to cases with overlapping groups can be achieved by replac-

















































































)2 ≤ ∥∥X˜Tg ~u∥∥22.










∥∥β̂g − β0g∥∥2. (4.14)
The inequality (4.12) is obtained by applying Cauchy-Schwartz inequal-
























































∥∥β̂g − βg∥∥22 ≤ κ2(ming λg)2 ∑
g∈H0
∥∥β̂g − βg∥∥22.
Finally, the inequalities (4.14) and (4.15) and the RE condition for












)} · λ2. (4.16)
This completes the proof.
In showing the convergence of Σ̂XY, we need an additional result for β̂
(or B̂) that is
∥∥β̂ − β0∥∥∞ = ∣∣B̂ − B∣∣∞ = op(1). This is a byproduct of
Theorem 1 because, on the event E1, we have
∣∣B̂−B∣∣2∞ = ∥∥β̂ − β∥∥2∞













which converges to 0.
We next prove the convergence of
∥∥ΣˆXX−ΣXX∥∥F, which is equivalent to
the convergences of
∥∥Σ̂f−Σf∥∥F and ∥∥Σ̂ν−Σν∥∥F. To show the convergence,
we need a few lemmas, which are stated below with proofs provided.
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Recall that we estimate f̂i, i = 1, 2, . . . , n, by solving
1
2














































f˜i1, f˜i2, . . . , f˜iG0
)T
. The first









We show that its sample variance consistently estimate Σf .11 which defines
ΣXX.






















i → Σf .11 and Σf in probability, (4.19)
respectively.
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Proof of Lemma 1
Proof. Let A0 be the matrix by the first G0 columns of the p × G matrix
A corresponding to fi.1. The proof is simply by noting
f˜i.1 =
(
AT0 A0 + cnIG0
)−1
AT0 Xi, (4.20)

















































































AT0 ξ converges 0 almost surely as p increases by the








converges to Σf .11 in probability.
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The second lemma is an analogy of Theorem 3 of Fan and Li (2012),
which shows the consistency of f̂ in selecting non-zero random factors from
f.1, f.2, . . . , f.G.
Lemma 2. Under the assumption that:




AT0 A0 and Σf .11
are bounded from below and above, respectively.




























where a.k is the k−th column vector of A.













to ∞ with n→∞,
we have, with probability tending to 1,
{
j










)2 ≤ n−δ, (4.25)
for δ defined in the assumption (ii).
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Proof of Lemma 2
Proof. The proof of the lemma is a direct application of Theorem 3 of
Fan and Li (2012). The theorem requires the regularity conditions on (1)
the penalty function, (2) the eigenvalues of the matrices related with the
design matrix A, and (3) the conditions for λ, n, and p. In this section,
we use the grouped lasso regression where its penalty function automati-
cally satisfies (1). Thus, we do not need it. The conditions (i) and (ii) of
our lemma are the simplified version of the condition for An required by
Condition 3 of Fan and Li (2012). The simplification is done using the fact
that An is the Kronecker product of the p × G matrix A and the n × n
identity matrix In
1. Finally, Fan and Li (2012) requires three condition
for the samples sizes (n and p) and λ. With the notations of our problem,














G0 →∞. Here, (b) implies (c) and the condition (iii) of the
lemma are equivalent to (a) and (b).
1To facilitate the interpretation, we provide matching notations between ours and




















∣∣f̂j 6= 0, 1 ≤ j ≤ np} =J0} (4.26)
approaches 1, we restrict our discussion to the event E2 below. In addition,
for notational simplicity, we let G0 = G, A = A0, f̂ = f˜ , f̂i = f˜i = f˜i.1 and
Σf = Σf .11. With this simplified notations, the following lemma (Lemma
3) provides a representation to f̂ which plays a key role in showing the
convergence of ΣXX.































Proof of Lemma 3
Proof. The identity (4.27) is straightforward by the definition of f̂i. In
























where the order is obtained by observing 1
p
AT0 A0 has the limit whose small-














as n and p increases. The order of the second term is again from the













∥∥f̂i − fi∥∥22 = Op( 1√np
)
.
The theorem below (Theorem 2) is analogous to Theorem 5 of Fan et al.
(2013), which shows the convergence of Σ̂Υ to ΣΥ in the Frobenius norm.
Recall that Σ̂Υ is the general thresholding (GT) (Rothman et al., 2009) of
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the sample covariance matrix of residuals
ξ̂i = Xi −Af̂i, i = 1, 2, . . . , n.
Theorem 5 of Fan et al. (2013) states that, if the above residuals ξ̂i are close
to ξi in the sense that max1≤j≤G
∑n
i=1
∥∥ξ̂i − ξi∥∥22 = op(a2n) with an = o(1)
and max1≤i≤n,1≤j≤G
∣∣ξ̂ij − ξij∣∣ = op(1), the GT of the sample covariance
matrix, denoted by Σ̂Υ converges to the covariance matrix of ξi, denoted
by ΣΥ, in the spectral norm under regularity conditions on ΣΥ, ξij, and
fij. The theorem below shows that ξ̂i are close enough to ξi to show the
convergence of Σ̂Υ in both the spectral and the Frobenius norm. We remark
that we assume the adaptive thresholding by Cai and Liu (2011), not that
in Fan et al. (2013). As claimed by Fan et al. (2013) , Theorem 5 and
other results in their section 3.2 are still true for the adaptive thresholding
by Cai and Liu (2011). The difference between two are from thresholding




, whereas Fan et al.








. Here, we use the version of Theorem 5 of




without repeating their proof.
Theorem 2. Suppose we assume that:
(i) The smallest and the largest eigenvalues of Σν is bounded by positive
constants Cmin,ν and Cmax,ν from below and above, respectively.
(ii) The variables ij and fij satisfy the sub-Gaussianality in the sense
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that there are r1, r2 > 0 and b1, b2 > 0 such that
P
(|ij| > s) ≤ exp{−(s/b1)r1} and P(|fij| > s) ≤ exp{−(s/b2)r2}.
(4.29)
Then, on the event E2, we have
∥∥Σ̂υ − Συ∥∥2F = Op(p log pn · C2p
)
, (4.30)
where Cp = max1≤J≤p
∣∣{1 ≤ k ≤ p | cov(ξij, ξik) 6= 0}∣∣.
Proof of Theorem 2
Proof. The proof of the theorem is mainly same with that of Theorem 5
of Fan et al. (2013). We simply show that ξ̂i are close to ξi. From the
identity in Lemma 3, we have









∥∥ξ̂i − ξi∥∥22 ≤ ∥∥A∥∥2F 1n
n∑
i=1
∥∥f̂i − fi∥∥22 = Op( 1√n
)
.
On the other hand,






where aj. is the j-th row vector of the matrix A. Using the Cauchy-Schwarz
inequality, (
ξ̂ij − ξij












as both n and p increases.
We next find that












Σ̂ν(j, k)− Σν(j, k)
)2
,
which, using the same argument of the proof of Theorem 5 of Fan et al.












Finally, in Theorem 3, we prove the convergence of ΣˆXX to ΣXX in the
Frobenius norm. This, together with Theorem 2, show the convergence of
Σ̂XY to ΣXY in the Frobenius norm.
Theorem 3. Under the assumptions of Lemma 2 and Theorem 2, on the
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set E2, we have
∥∥ΣˆXX −ΣXX∥∥2F = Op(p log pn C2p
)
. (4.31)
Proof of Theorem 3













































































































































and this completes the proof.
4.4 Selection consistency of f̂ and B̂
The consistency of f̂ in selecting degenerated elements in f is shown in
Lemma 2. In this section, we only focus on the selection consistency of B̂.
We make two assumptions to show the result. First, we assume the smallest






are bounded below and above












Let E3 be the event that there exists a solution β̂ such that
∥∥β̂g∥∥2 > 0
for all g ∈H0 and β̂g = 0 for all g ∈H c0 .




converges to 1 as n→
∞.
4.5 Proof of Theorem 4
Proof. The proof of the selection consistency starts with the sub-gradient
of










































β̂j∥∥β̂g∗∥∥2 , j ∈ L0,∑
g∗:j∈Ig∗ λg∗zg∗ , j ∈ L c0
,
where zg∗ are generic vectors such that
∥∥zg∗∥∥2 ≤ 1 for all g∗.
The event E3 holds if and only if


































(∥∥∥β̂L0 − β0L0∥∥∥∞ > α) = 1
where α = minh∈H0
∥∥βh∥∥∞ and (b): the probability of the event, for every




converges to 1 also as n increases.
First, we show (a):
P

























X˜T0  and d0 =
∑
g∈H0 dg.
Second, we show (b): For j ∈ L c0 ,
∣∣∣η̂j∣∣∣ =



































































































 · (1− )
by using the second assumption.
In the second term in (4.36), let W =
(




















































We first conducted extensive simulation studies to evaluate the perfor-
mance of the method. We generated the data based on Equations (3.5) and
(3.14) with n = 1000, p = 110, G = 10, with two distinct group matrix A
of different degrees of overlap between the groups. The first group matrix
corresponds to a structure with significant overlapping between groups and
the other an almost mutually exclusive grouping structure. We call these














1 if g = 1, ` ≤ 14
1 if g = 10, ` ≥ 95





Figure 5.1 The group structure in A(1) and A(2) (large overlap between
groups).
Note that most p elements of X belong to 2 groups in both cases. Next,
we randomly selected 5 groups of variables to be associated with non-zero
factors, and simulated their factors independently from
fi,g ∼ N (0, 1) independently 6 ≤ g ≤ 10,∀i. (5.3)
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independently for i = 1, . . . , n and ` = 1, . . . , p, where σ is the noise pa-
rameter for Stage 1 estimation.
For the simulation of the response variables Y, we used a univariate
response (q = 1) for the simplicity of simulation. Hence the regression
matrix B has a dimension of p× 1 and we simulated Y from
Yi = X
T




1 for 100 ≤ ` ≤ 110
0 otherwise.
(5.6)






for i = 1, . . . , n and all `, where τ is therefore the noise parameter for
Stage 2 estimation. For the two grouping structures as described above,
we have generated 100 simulation data sets for the following four pairs of
stage-specific noise levels in X and Y: (σ, τ) = (1, 1), (1, 2), (2, 1), (2, 2).
Using these data sets, we will evaluate our method comparatively with soft
thresholding in terms of two key asymptotic properties of the our estimator,
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namely sparsistency and consistency.
5.2 Result
Since the data was generated by emulating the systematic component
for the Stage 1 model, we used the sensitivity and specificity in the detection
of non-zero elements in Σˆ0XX := AΣˆfA
′
and Σˆ0XY := AΣˆfA
′
B. For the
Stage 1 evaluation, we calculated:
Sensitivity =
number of factors correctly estimated to be non-zero
number of factors that are non-zero
Specificity =
number of factors correctly estimated to be zero
number of factors that are zero
.
Likewise for Stage 2 evaluation, we calculated
Sensitivity =
number of elements in Σˆ0XY correctly estimated to be non-zero
number of elements that are non-zero
Specificity =
number of elements in Σˆ0XY correctly estimated to be zero
number of elements that are zero
.
Across all simulation settings, accounting for large and small overlap be-
tween groups and variable degree of noise, the proposed method that incor-
porated the true group structure achieved significantly better results than
element-wise shrinkage estimator with soft-thresholding operator in terms
of sensitivity and specificity. First, Figures 5.2, 5.3,5.6 and 5.7 showed that
Stage 1 estimation identified non-zero and zero factors with high sensitiv-
ity and specificity. The results shown is for the case with the highest noise
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levels (σ, τ) = (2, 2) and grouping structure with a high degree of overlap
A(2), and the performance improved as we lowered the level of noise and
groups sharing fewer genes (A(1)). Figures 5.4, 5.5, 5.8, 5.9 is showing
the sensitivity and specificity for detecting non-zero elements in the final
estimate of Σˆ0XY, in which the Stage 2 estimation of the proposed esti-
mator outperforms the element-wise shrinkage estimator at all degrees of
shrinkage represented by the Frobenius norm of the difference between the
true cross-covariance matrix and the estimated matrix. Overall, the simu-
lations under all parameter settings indicated that the proposed estimator
recovers the non-zero factors of f and non-zero elements in the systematic















































Figure 5.2 Sensitivity as a function of the tuning parameter in Stage 1
estimation under four scenarios: (σ, τ) = (1, 1), (σ, τ) = (1, 2), (σ, τ) =
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Figure 5.4 Specificity of the overall estimate as a function of the Frobe-





0 10 20 30 40 50





shrinkage soft thresholding group lasso





0 10 20 30 40 50





shrinkage soft thresholding group lasso





0 20 40 60





shrinkage soft thresholding group lasso





0 20 40 60





shrinkage soft thresholding group lasso
specificity of cross covariance estimators
Figure 5.5 Specificity of the overall estimate as a function of the Frobe-















































Figure 5.6 Sensitivity as a function of the tuning parameter in Stage 1
estimation under four scenarios: (σ, τ) = (1, 1), (σ, τ) = (1, 2), (σ, τ) =
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Figure 5.8 Specificity of the overall estimate as a function of the Frobe-
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Figure 5.9 Specificity of the overall estimate as a function of the Frobe-
nius norm of the estimated cross covariance matrix.
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CHAPTER 6
Analysis of DNA methylation
and mRNA expression in
TCGA data
We applied the proposed method to the integrative analysis of DNA
methylation and mRNA transcript expression data in TCGA-BRCA co-
hort. We used Gene Ontology terms (Ashburner et al., 2000) as gene group
information, especially the set of GO terms containing 10 to 50 genes in the
definition. The choice of GO terms is deliberate since GO is a relational
database with hierarchical structure: each GO term has a parent term that
is larger in size and less specific in definition. By limiting the GO term size
in this range, we can reduce the number of shared genes between the GO
terms, which has to be controlled to a degree to meet the minimal overlap
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requirement for the estimators in both stages. To focus on the biological
functions implicated in different tumor subtypes, we further reduced the
data to the genes involved in the kinase signalling networks, consisting of
227 kinases and 764 non-kinase substrates that are experimentally validated
and appear in the iRefIndex database (Razick et al., 2008). All 991 genes
were present in the mRNA data (RNA-seq), and 958 genes were present in




























Figure 6.1 Model selection via AIC for the first stage estimation in the
K2S analysis. (A) AIC versus shrinkage parameter. (B) The number of
selected groups at the corresponding shrinkage parameter.
Figure 6.1 shows the AIC curve and the number of selected groups with
non-zero factors in the stage 1 estimation. We selected the optimal thresh-
old λ = 15 where the curve became flat, which yielded 33 non-zero factors
reported in Table 6.1. As we focused on the genes involved in the kinase
signalling network, the selected groups included many phosphorylation-
mediated gene expression regulation terms for signal transduction as well
as other functions such as immune response, inflammatory response, an-
giogenesis that are commonly implicated in genomic studies of tumors. In-
terestingly, estimated factors f̂i were mostly positively correlated with the
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GO ID GO term name
GO:0001525 Angiogenesis









activation of cystein-type endopeptidase activity




GO:0007169 transmembrane receptor protein tyrosine kinase signaling




GO:0007611 learning or memory
GO:0008083 growth factor activity
GO:0009897 external side of plasma membrane
GO:0009967 positive regulation of signal transduction
GO:0010628 positive regulation of gene expression
GO:0016021 integral component of membrane
GO:0016324 apical plasma membrane
GO:0016477 cell migration
GO:0019904 protein domain specific binding
GO:0030335 positive regulation of cell migration
GO:0031295 T cell costimulation
GO:0034220 ion transmembrane transport
GO:0042110 T cell activation
GO:0043410 positive regulation of MAPK cane
GO:0051092 positive regulation of NF-kappaB transcription factor activity
Table 6.1 The selected factors (GO terms) in the first stage of the kinase-
to-substrate analysis. The GO terms in bold are the ones in which the
estimated factors from DNA methylation data were clearly negatively cor-
related with average mRNA expression data.
average DNA methylation patterns, but not in all GO terms. As shown in
some panels of Figure 6.2A, the estimated factors did not exactly match
the average DNA methylation profiles in all GO terms, especially in the
GO terms that share many genes with at least one other term(s), e.g. T
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Estimated factors Estimated factors Estimated factors Estimated factors
Figure 6.2 (A) Average DNA methylation levels versus estimated fac-
tors representing four GO terms, which are positively correlated as ex-
pected. (B) Average mRNA expression levels versus estimated factors rep-
resenting the GO terms. (C) Average mRNA data versus average DNA
methylation data for the same GO terms.
cell activation and T cell co-stimulation sharing many member genes with
immune response term. In these cases, the factors tend to be shrunken
toward zero compared to the average methylation levels, but the correla-
tion with the average mRNA expression within the same term tended to
be more negative, as we shall discuss later.
As mentioned above, the proposed method allows us to express the
variance-covariance matrix of DNA methylation data as the sum of a sys-




Figure 6.3 (A) Sample covariance matrix of DNA methylation data,
indicating largely positive correlation between different genes. (B) Esti-
mated covariance matrix ΣˆXX in Stage 1. (C) The systematic component
AΣˆfA
T in Stage 1 estimation. (D) The same matrix in (C) after hierar-
chical clustering.
sample covariance matrix and the one obtained by the two-stage estima-
tion, respectively. Note that the matrix shown in Figure 6.3B is the sum of
the two matrices, the systematic component associated with 33 GO terms
shown in Figure 6.3C and the residual component (not shown, Figure 6.3D
is the same matrix after hierarchical clustering). A striking realization in
this decomposition is the sparsity of the systematic component shown in






Figure 6.4 (A) Sample cross-covariance matrix between DNA methyla-
tion data and mRNA expression data. (B) Cross-covariance matrix ΣˆXY
with a soft-thresholding estimator. (C) Cross-covariance estimated by the
two-stage estimator Σ̂XXB̂. (D) The systematic component AΣˆfA
TB̂
of the cross-covariance matrix. (E) The residual cross-covariance matrix
Σˆυ.(F) The systematic component in (D) after hierarchical clustering.
information explain a relatively small proportion of total variability in the
DNA methylation data. Although indeed there does not exist a concerted
regulatory program of DNA methylation at the pathway level, another
plausible explanation is that the GO terms used in this analysis does not
capture all functional clusters of genes due to lack of discoveries or incom-
pleteness of the database. Moreover, as shown in the example diagram of
T cell co-stimulation in Figure 2.1, it may be difficult to expect all 10 to
50 genes in a pathway to be co-regulated to be represented by a common
factor. Hence a more careful curation of co-regulated gene groups from
the GO terms can improve the proportion of variability explained by the
systematic component.
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The ultimate goal of our analysis was to identify the pathways in which
DNA methylation is the major driver of mRNA expression regulation mech-
anism, i.e. the cross-covariance matrix estimation. Figures 6.4A, 6.4B, 6.4C
are the sample cross-covariance matrix with no shrinkage, with shrinkage
by soft-thresholding operator with cross validation-based tuning parameter
selection, and the estimate from the proposed two-stage estimator, respec-
tively. The real advantage of the proposed method is the decomposition
ΣˆXY = AΣˆfA
TB̂ + ΣˆυB̂, where the former is shown in Figure 6.4D and
6.4F before and after hierarchical clustering respectively and the latter is
shown in Figure 6.4E. The upper left corner (blue) of Figure 6.4F represents
the groups of genes in which DNA methylation was negatively correlated
with mRNA expression amongst themselves, indicating that DNA methy-
lation played a significant regulatory role on the mRNA expression in those
genes at the pathway level. The upper right corner (red) represents two dif-
ferent gene sets for which DNA methylation of one set of genes is positively
correlated with mRNA levels of the other set of genes, which carries no
biologically meaningful covariances with respect to methylation-mediated
RNA expression.
With regard to the GO terms selected in Stage 1, the scatter plot of
estimated factors against average mRNA expression patterns in those GO
terms (Figure 6.2B) indicates negative correlation with the mRNA data,
suggesting the repressive role of methylation on the transcript output. In-
terestingly, the comparison between Figure 6.2B and Figure 6.2C suggests
that the estimated factors are much better correlated with the average
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methylation levels, and this verifies that the shrunken estimates of factor
components are able to reveal the regulatory structure with improved clar-
ity. These findings are also corroborated by previous breast cancer oncoge-
nomic reports, such as methylation-driven intermediate filament dynam-
ics (Noetzel et al., 2010) and cytoskeletal component (Ulirsch et al., 2013),





In this work, we have developed a two-stage estimator of cross-covariance
matrix, which takes advantage of existing group information between the
variables. Despite the detour we take in obtaining shrunken estimates, the
advantage of our method lies in its ability to tease out biologically relevant
signals from the residual effects, thereby facilitating meaningful interpre-
tation of data. In addition, we have provided theoretical properties such
as estimation consistency and model selection consistency on both stages
with appropriate conditions, using slight modifications of existing work.
Our extensive simulation studies have demonstrated that these properties
are valid even when the group information is incomplete, since the residual
component captures the rest of the variability unexplained by the grouped
variables (factors in the systematic components). Compared to the POET
estimator, the major difference in the first stage estimator was that the
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factors are defined by the previously defined gene grouping information, as
opposed to numerically derived linear combinations of variables, i.e. the
first K principal components in their method. The second stage estima-
tor of multivariate linear regression model is a modification of group lasso
allowing overlap of group membership (Jacob et al., 2009; Li et al., 2015;
Simon et al., 2013), which has been previously proposed. We have formally
specified the restrictions on group overlap (in Equation 4.7). Our method
handles overlapping by reducing such groups to a set of non overlapping
groups. This approach is different from the method in Li et al. (2015),
where their algorithm directly accounts for the group overlaps.
Our analysis of the human kinase network in TCGA BRCA data recov-
ered previously known hypermethylation activities in the cancer genomes
that were validated in independent study populations outside TCGA, sug-
gesting the validity of our approach and increased opportunity of further
discoveries of gene expression regulation activities through multi-omics data
sets. This can be achieved through application of our method to broader
gene sets (e.g. outside kinase signaling networks), or analysis of different
data sources such as microRNA paired with protein expression data. We
have also illustrated that element-wise shrinkage estimation, in spite of the
ease of implementation and numerical optimality of estimation procedures,
is likely to capture indirect correlations that are not biologically relevant in
the context of joint analysis of DNA methylation and mRNA expression.
As biological systems are operated by densely connected networks of molec-
ular machineries, i.e. biological functions or pathways, utilizing previously
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characterized gene group information is expected to improve the biological
relevance of selected covariance terms.
The proposed method is far from flawless nonetheless, which warrants
further improvement. First, we assumed that the factors {f·g}Gg=1 represent
the common effects shared by all members of the individual groups, and
this assumption can be rigid when the group size is large since there can be
subgroups of genes that are regulated differently within the group. This is
best exemplified in the PI3K-AKT1-mTORC2 complex genes included in
Figure 2.1, located in the middle rows of the two heat maps, which clearly
indicate those genes violate our common factor assumption. In addition,
the factors can be un-estimable as the group definitions share too many
common genes between one another. Therefore it is crucial to screen the
gene group definition before fitting the group lasso.
Second, although the simulation studies showed that the systematic
component can be estimated consistently, our TCGA data analysis showed
that the proportion of cross-covariance explained by the systematic compo-
nent was small. The main reasons for this outcome can be two-fold. Since
the proposed estimation in the first stage is sequential, first applied to the
factors and subsequently applied to the residuals, it is possible that the fac-
tors could have been underestimated because it was estimated by shrinkage
first without simultaneously estimating penalizing residuals. In addition,
it is possible that the AIC was suboptimal for model selection, especially
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when the AIC curves tended to be monotone decreasing (rather than U-
shaped) as the shrinkage parameter increased. This observation likely has
to do with the fact that the number of factor terms increases along with
the sample size, and thus it may be necessary to devise a new model se-
lection criteria for this type of problems. Besides using the AIC for model
selection, we have also tried using the Bayesian information criterion (BIC)
(Schwarz, 1978) and Cp statistic (Mallows, 1973) for model selection but
the results are not shown here. Neither of this two performed reasonably
in the simulation studies. In most cases, either all or none of the features
were selected. The cause of such failures might be worth investigating in
future work.
Lastly, our current penalty structure yields either all zero or all non-
zero estimates in each gene group. However, it is possible that further
shrinkage on the factor estimates {f·g}Gg=1 for some subjects but not all,
e.g. L1 penalty on the factors of each individual, can be imposed and it
can provide more interpretable results. For example, DNA methylation-
mediated mRNA regulation is neither the only mechanism nor universal in
every individual in a study such as TCGA, which profiles tumor samples
of various molecular types and thus one type of gene expression regulation
mechanism is turned on or off in a subset of tumor specimens only. How-
ever, we consider these potential refinements beyond the scope of this work
and leave them to future research.
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